NEW YORK, Aug. 22, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of AT&T Inc.. Shareholders who purchased shares of T during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead…

NEW YORK, Aug. 22, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Verizon Communications Inc.. Shareholders who purchased shares of VZ during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….

NEW YORK, Aug. 22, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Hayward Holdings, Inc.. Shareholders who purchased shares of HAYW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….

NEW YORK, Aug. 22, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of BioXcel Therapeutics, Inc.. Shareholders who purchased shares of BTAI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….

NEW YORK, Aug. 22, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc.. Shareholders who purchased shares of RAIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….

NEW YORK, Aug. 22, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of RTX Corporation f/k/a Raytheon Technologies Corporation. Shareholders who purchased shares of RTX during the class period listed are encouraged to contact the firm regarding possible…

NEW YORK, Aug. 22, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Eos Energy Enterprises, Inc.. Shareholders who purchased shares of EOSE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….

BERGEN, Norway, Aug. 22, 2023 /PRNewswire/ — BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced today that additional clinical data of bemcentinib in combination with…

SINGAPUR, 22. August 2023 /PRNewswire/ — ChainUp, ein führender globaler Anbieter von Blockchain-Lösungen, hat drei international anerkannte Sicherheitsakkreditierungen erhalten – die Zertifizierungen ISO/IEC 27001, 27017 und 27018. Nach Bekanntgabe des Erhalts der Zertifizierung SOC 2…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.